Ebola isn't just killing people. It's ravaging West Africa's economy.

The Ebola virus is a vicious illness in which victims bleed from the eyes, mouth, and other bodily orifices. The ongoing outbreak is already the worst in history, with a death toll that has topped more than 1,200 as of Tuesday, according to figures compiled by the World Health Organization.
What's less widely known are the effects of Ebola on the economies of the countries afflicted by the outbreak, which include Guinea, Sierra Leone, Liberia, and Nigeria. As David Francis of Foreign Policy writes:
The World Bank estimates that Guinea's GDP will shrink between 3.5 and 4.5 percent this year as Ebola roils the agricultural sector and discourages regional trade. Liberia's finance minister, Amara Konneh, lowered the country's GDP estimates by 5.9 percent because of the outbreak. Bismarck Rewane, CEO of the Financial Derivatives Company, a Lagos-based financial advisory and research firm that manages $18 million in assets, told CNBC Africa on Monday, Aug. 18, that Nigeria could lose at least $3.5 billion of its $510 billion GDP. Moody's has already warned that the virus could hinder the region's energy sector. [Foreign Policy]
He adds that the total damage will remain unknown until the outbreak is over, but "[i]f history is any indication, the blow is likely to be enormous and disproportionate to the death toll. For instance, the 2003 SARS outbreak, which killed 800 people, inflicted some $50 billion in damages to the global economy, according to the Economist. Ebola could be even worse."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
John Aziz is the economics and business correspondent at TheWeek.com. He is also an associate editor at Pieria.co.uk. Previously his work has appeared on Business Insider, Zero Hedge, and Noahpinion.
-
Alterations: 'riveting' 1970s tailoring comedy is a lot of fun
The Week Recommends 'Retro gem' from the National Theatre's Black Plays Archive 'springs into life' from the start
By The Week UK Published
-
Has World Book Day become a 'horror show'?
Talking Point Annual event to encourage children to read for pleasure is sore spot for parents under 'growing pressure' to create character costumes
By Harriet Marsden, The Week UK Published
-
Festival of Sport announces exciting media partnership with The Week Junior
Festival of Sport, the UK’s premier family-friendly sports festival, has officially teamed up with The Week Junior as its exclusive media partner.
By The Week Junior Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published